Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 55, 2021 - Issue 6
Journal homepage
936
Views
0
CrossRef citations to date
0
Altmetric
Articles

Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer has no value for treatment decisions and low correlation with nodal status

S. Tenningea Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenView further author information
,
H. Mogosa Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenView further author information
,
E. Erikssonb Department of Radiation Sciences, Diagnostic Radiology, Umeå University, Umeå, SwedenView further author information
,
H. Netterlinga Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenView further author information
,
S. Pelanderc Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, SwedenView further author information
,
M. Johanssona Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden;d Department of Urology, Sundsvall Hospital, Sundsvall, SwedenView further author information
,
F. Alamdarie Department of Urology, Västmanland Hospital, Västerås, SwedenView further author information
,
Y. Hugec Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, SwedenView further author information
,
F. Aljaberyc Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, SwedenView further author information
,
J. Svenssonf Department of Statistics, Umeå School of Business, Economics and Statistics, Umeå University, Umeå, SwedenView further author information
,
J. Styrkea Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden;d Department of Urology, Sundsvall Hospital, Sundsvall, SwedenView further author information
&
A. Sherifa Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-3675-3050View further author information
ORCID Icon show all
Pages 455-460 | Received 15 Apr 2021, Accepted 13 Sep 2021, Published online: 30 Sep 2021

References

  • Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6):4–34.
  • Lotan Y, Choueiri TK. Clinical presentation, diagnosis, and staging of bladder cancer. In: Lerner SP, Shah S, editors. UpToDate clinical presentation, diagnosis, and staging of bladder cancer; 2020. https://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-of-bladder-cancer
  • Witjes JA, Compérat E, Cowan NC, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–475.
  • von der Maase H, Hansen S, Roberts J, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol. 2000;18(17):3068–3077.
  • Sherif A, Holmberg L, Rintala E, et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two nordic studies. Eur Urol. 2004;45(3):297–303.
  • Claire V. Advanced bladder cancer (ABC) Meta-analysis collaboration neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) Meta-analysis collaboration. Eur Urol. 2005; 48:202–205. discussion 205–6.
  • Rosenblatt R, Sherif A, Rintala E, et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer. Eur Urol. 2012;61(6):1229–1238.
  • Petrelli F, Coinu A, Cabiddu M, et al. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis. Eur Urol. 2014;65(2):350–357.
  • Sherif A. The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada-space for improvement with regular and organized multidisciplinary team meetings. Transl Androl Urol. 2018;7(3):508–510.
  • Fukui T, Matsui Y, Umeoka S, et al. Predictive value of radiological response rate for pathological response to neoadjuvant chemotherapy and post-cystectomy survival of bladder urothelial cancer. Jpn J Clin Oncol. 2016;46(6):560–567.
  • Mogos H, Eriksson E, Styrke J, et al. Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis-results of a single Centre retrospective prognostic study. Transl Androl Urol. 2020;9(3):1062–1072.
  • Schwartz LH, Litière S, de Vries E, et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 2016; 62:132–137.
  • Chang SS, Hassan JM, Cookson MS, et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol. 2003;170(4 Pt 1):1085–1087.
  • Jerlström T, Chen R, Liedberg F, et al. No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study. World J Urol. 2020;38(2):381–388.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.